The Genetic Basis for Cancer Therapeutics:

Cancer is driven by genetic changes that cause malignant cells to grow aggressively and spread throughout the body. A dynamic disease, cancer evolves in response to treatment, leading to resistance. The genetic changes that allow cancers to grow and thrive can also create unique vulnerabilities, which researchers hope to exploit for new, more effective treatments.

In this talk, Bill Sellers, director of the Cancer Program at the Broad Institute of MIT and Harvard, will share how researchers at the Broad and its partner institutions are thinking about these challenges of treating cancer and how they are working to develop more effective and curative treatments. 
 

About the speaker:
Bill Sellers is a core institute member at the Broad and serves as director of the institute's Cancer Program. He is also a faculty member at Harvard Medical School, and faculty member and senior advisor to the president for experimental therapeutics at Dana-Farber Cancer Institute. He is a distinguished cancer scientist, with deep experience in cancer biology and cancer therapeutics. The Sellers Lab leverages the link between genetic alterations and cancer dependencies to elucidate new therapeutic hypotheses and develop novel therapeutics.